BDX - Becton Dickinson and Company - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0758871091

Medical Devices, Laboratory Equipment, Diagnostic Products, Syringes, Needles

Becton, Dickinson and Company is a global leader in the medical technology industry, providing a wide range of innovative products and solutions to healthcare institutions, physicians, researchers, and the general public worldwide.

The company operates through three main segments: BD Medical, BD Life Sciences, and BD Interventional. BD Medical focuses on developing and manufacturing medical supplies, devices, and equipment for various healthcare settings. This includes products such as IV catheters, syringes, needles, and medication delivery systems, as well as solutions for medication safety, infusion therapy, and supply management.

In addition to medical supplies, BD Medical also offers a range of products for vascular access, anesthesia, and enteral nutrition, as well as systems for medication compounding, automated dispensing, and inventory management. This segment is dedicated to improving patient care and safety, while also enhancing the efficiency and effectiveness of healthcare providers.

BD Life Sciences, on the other hand, is focused on advancing the discovery and diagnosis of diseases. This segment offers a broad portfolio of products and solutions for specimen collection, blood and tuberculosis culturing, molecular testing, and microbiology laboratory automation. BD Life Sciences also provides a range of reagents, antibodies, and kits for gene expression analysis, as well as diagnostic and monitoring tools for clinical oncology, immunology, and transplantation.

The BD Interventional segment is dedicated to developing and manufacturing innovative products for surgical and interventional procedures. This includes hernia and soft tissue repair products, biological and bioresorbable grafts, biosurgery products, and surgical infection prevention solutions. The segment also offers peripheral intervention products, urology and critical care products, and other surgical solutions designed to improve patient outcomes and reduce healthcare costs.

With a rich history dating back to 1897, Becton, Dickinson and Company is headquartered in Franklin Lakes, New Jersey, and is committed to advancing the world of health through innovative solutions and partnerships. To learn more about the company and its products, visit https://www.bd.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for BDX - Becton Dickinson and Company  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for BDX - Becton Dickinson and Company  - Stock & Dividends

BDX Stock Overview

Market Cap in USD 67,419m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1987-01-01

BDX Stock Ratings

Growth 5y 8.51
Fundamental 31.4
Dividend 40.0
Rel. Performance vs Sector -0.82
Analysts 4.24/5
Fair Price Momentum 223.28 USD
Fair Price DCF 278.09 USD

BDX Dividends

Dividend Yield 12m 1.60%
Yield on Cost 5y 1.68%
Dividends CAGR 5y 4.02%
Payout Consistency 79.2%

BDX Growth Ratios

Growth 12m -7.74%
Growth Correlation 12m -27%
Growth Correlation 3m 52%
CAGR 5y 0.98%
CAGR/Mean DD 5y 0.09
Sharpe Ratio 12m -0.64
Alpha vs SP500 12m -26.15
Beta vs SP500 5y weekly 0.45
ValueRay RSI 66.51
Volatility GJR Garch 1y 18.09%
Price / SMA 50 0.95%
Price / SMA 200 1.36%
Current Volume 712.9k
Average Volume 20d 1284.9k

External Links for BDX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BDX stocks?
As of October 05, 2024, the stock is trading at USD 238.22 with a total of 712,860 shares traded.
Over the past week, the price has changed by -1.36%, over one month by +1.21%, over three months by +5.02% and over the past year by -8.92%.
What are the forecast for BDX stock price target?
According to ValueRays Forecast Model, BDX Becton Dickinson and Company will be worth about 241.2 in October 2025. The stock is currently trading at 238.22. This means that the stock has a potential upside of +1.23%.
Issuer Forecast Upside
Wallstreet Target Price 273.4 14.8
Analysts Target Price 301.2 26.4
ValueRay Target Price 241.2 1.23